Overview
- 24 inspections across 24 sites are on record.
- 58 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2026-06-04.
At a glance
Inspections
24
Sites
24
Observations
58
Career since
Jun 2023
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Nippon Sanso Matheson, Inc. | 4 Jun 2026 | Human Drugs | On file |
| Avara Pharmaceutical Technologies, Inc. | 2 Jun 2026 | Human Drugs | |
| Nova Biologicals, Inc. | 6 Apr 2026 | Human Drugs | View 483 → |
| Eosera, Inc. | 20 Mar 2026 | Human Drugs | View 483 → |
| AMPAC Fine Chemicals Texas, LLC | 12 Feb 2026 | Human Drugs |
Sites inspected
Nippon Sanso Matheson, Inc.Lawton, United States1 insp.
Avara Pharmaceutical Technologies, Inc.Norman, United States1 insp.
Nova Biologicals, Inc.Conroe, United States1 insp.
Eosera, Inc.Fort Worth, United States1 insp.
AMPAC Fine Chemicals Texas, LLCLa Porte, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Margaret M Annes5 shared
Rodney L Tinzie3 shared
Camerson E Moore2 shared
Saundrea A Munroe2 shared
Bijoy Panicker2 shared
Milton J De Jesus Tavarez1 shared
Timothy H Vo1 shared
Megan T Ziegler1 shared
Samantha E Cleek1 shared
Clinton J Lott1 shared
Full investigator report
Get the verbatim findings behind Oluwasefunm Agbanigo's 58 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site